1.    Structure, function and diversity of the healthy human microbiome. nature. 2012;486(7402):207-14.
2.    Ravel J, Gajer P, Abdo Z, Schneider GM, Koenig SS, McCulle SL, et al. Vaginal microbiome of reproductive-age women. Proceedings of the National Academy of Sciences. 2011;108(supplement_1):4680-7.
3.    O’Hanlon DE, Moench TR, Cone RA. Vaginal pH and microbicidal lactic acid when lactobacilli dominate the microbiota. PloS one. 2013;8(11):e80074.
4.    France M, Alizadeh M, Brown S, Ma B, Ravel J. Towards a deeper understanding of the vaginal microbiota. Nature microbiology. 2022;7(3):367-78.
5.    Gajer P, Brotman RM, Bai G, Sakamoto J, Schütte UM, Zhong X, et al. Temporal dynamics of the human vaginal microbiota. Science translational medicine. 2012;4(132):132ra52-ra52.
6.    Acidification V. Acid Production by Vaginal Flora In Vitro Is. Infect Immun. 1999;67(10):5170.
7.    Holdcroft AM, Ireland DJ, Payne MS. The vaginal microbiome in health and disease—what role do common intimate hygiene practices play? Microorganisms. 2023;11(2):298.
8.    Muzny CA, Balkus J, Mitchell C, Sobel JD, Workowski K, Marrazzo J, et al. Diagnosis and management of bacterial vaginosis: summary of evidence reviewed for the 2021 Centers for Disease Control and Prevention sexually transmitted infections treatment guidelines. Clinical infectious diseases. 2022;74(Supplement_2):S144-S51.
9.    cdc.gov. Bacterial Vaginosis 2021 [Available from: https://www.cdc.gov/std/treatment-guidelines.
10.Byrne EH, Doherty KE, Bowman BA, Yamamoto HS, Soumillon M, Padavattan N, et al. Cervicovaginal bacteria are a major modulator of host inflammatory responses in the female genital tract. Immunity. 2015;42(5):965-76.
11.Koedooder R, Singer M, Schoenmakers S, Savelkoul PH, Morré SA, de Jonge JD, et al. The vaginal microbiome as a predictor for outcome of in vitro fertilization with or without intracytoplasmic sperm injection: a prospective study. Human reproduction. 2019;34(6):1042-54.
12.Moreno I, Codoñer FM, Vilella F, Valbuena D, Martinez-Blanch JF, Jimenez-Almazán J, et al. Evidence that the endometrial microbiota has an effect on implantation success or failure. American journal of obstetrics and gynecology. 2016;215(6):684-703.
13.Moreno I, Garcia-Grau I, Perez-Villaroya D, Gonzalez-Monfort M, Bahçeci M, Barrionuevo MJ, et al. Endometrial microbiota composition is associated with reproductive outcome in infertile patients. Microbiome. 2022;10(1):1.
14.Fettweis JM, Serrano MG, Brooks JP, Edwards DJ, Girerd PH, Parikh HI, et al. The vaginal microbiome and preterm birth. Nature medicine. 2019;25(6):1012-21.
15.Integrative H. The Integrative Human Microbiome Project: dynamic analysis of microbiome-host omics profiles during periods of human health and disease. Cell host & microbe. 2014;16(3):276-89.
16.Wu M, Li H, Yu H, Yan Y, Wang C, Teng F, et al. Disturbances of vaginal microbiome composition in human papillomavirus infection and cervical carcinogenesis: A qualitative systematic review. Frontiers in Oncology. 2022;12:941741.
17.Peng Y, Tang Q, Wu S, Zhao C. Associations of Atopobium, Garderella, Megasphaera, Prevotella, Sneathia, and Streptococcus with human papillomavirus infection, cervical intraepithelial neoplasia, and cancer: a systematic review and meta-analysis. BMC Infectious Diseases. 2025;25(1):708.
18.Colonetti T, Saggioratto MC, Grande AJ, Colonetti L, Junior JCD, Ceretta LB, et al. Gut and Vaginal Microbiota in the Endometriosis: Systematic Review and Meta‐Analysis. BioMed research international. 2023;2023(1):2675966.
19.Pereira MP, Jones S, Costin JM, Pereira M, Costin J. Association of polycystic ovarian syndrome (PCOS) with vaginal Microbiome dysbiosis: A scoping review. Cureus. 2024;16(6).
20.Srinivasan S, Morgan MT, Fiedler TL, Djukovic D, Hoffman NG, Raftery D, et al. Metabolic signatures of bacterial vaginosis. MBio. 2015;6(2):10.1128/mbio. 00204-15.
21.Vitali B, Cruciani F, Picone G, Parolin C, Donders G, Laghi L. Vaginal microbiome and metabolome highlight specific signatures of bacterial vaginosis. European Journal of Clinical Microbiology & Infectious Diseases. 2015;34(12):2367-76.
22.Cohen CR, Wierzbicki MR, French AL, Morris S, Newmann S, Reno H, et al. Randomized trial of lactin-V to prevent recurrence of bacterial vaginosis. New England Journal of Medicine. 2020;382(20):1906-15.
23.Lev-Sagie A, Goldman-Wohl D, Cohen Y, Dori-Bachash M, Leshem A, Mor U, et al. Vaginal microbiome transplantation in women with intractable bacterial vaginosis. Nature medicine. 2019;25(10):1500-4.
24.Vodstrcil LA, Plummer EL, Fairley CK, Hocking JS, Law MG, Petoumenos K, et al. Male-partner treatment to prevent recurrence of bacterial vaginosis. New England Journal of Medicine. 2025;392(10):947-57.
25.Bing M, Forney L, Ravel J. The vaginal microbiome: rethinking health and diseases. Annu Rev Microbiol. 2012;66:371-89.
26.Amabebe E, Anumba DO. The vaginal microenvironment: the physiologic role of lactobacilli. Frontiers in medicine. 2018;5:389042.
27.Chee WJY, Chew SY, Than LTL. Vaginal microbiota and the potential of Lactobacillus derivatives in maintaining vaginal health. Microbial cell factories. 2020;19(1):203.
28.Zheng N, Guo R, Wang J, Zhou W, Ling Z. Contribution of Lactobacillus iners to vaginal health and diseases: a systematic review. Frontiers in cellular and infection microbiology. 2021;11:792787.
29.Miller EA, Beasley DE, Dunn RR, Archie EA. Lactobacilli dominance and vaginal pH: why is the human vaginal microbiome unique? Frontiers in microbiology. 2016;7:1936.
30.Song SD, Acharya KD, Zhu JE, Deveney CM, Walther-Antonio MR, Tetel MJ, et al. Daily vaginal microbiota fluctuations associated with natural hormonal cycle, contraceptives, diet, and exercise. MSphere. 2020;5(4):10.1128/msphere. 00593-20.
31.Romero R, Hassan SS, Gajer P, Tarca AL, Fadrosh DW, Nikita L, et al. The composition and stability of the vaginal microbiota of normal pregnant women is different from that of non-pregnant women. Microbiome. 2014;2(1):4.
32.Park MG, Cho S, Oh MM. Menopausal changes in the microbiome—a review focused on the genitourinary microbiome. Diagnostics. 2023;13(6):1193.
33.Mirmonsef P, Modur S, Burgad D, Gilbert D, Golub ET, French AL, et al. Exploratory comparison of vaginal glycogen and Lactobacillus levels in premenopausal and postmenopausal women. Menopause. 2015;22(7):702-9.
34.Lewis FM, Bernstein KT, Aral SO. Vaginal microbiome and its relationship to behavior, sexual health, and sexually transmitted diseases. Obstetrics & Gynecology. 2017;129(4):643-54.
35.Bakus C, Budge KL, Feigenblum N, Figueroa M, Francis AP. The impact of contraceptives on the vaginal microbiome in the non-pregnant state. Frontiers in Microbiomes. 2023;1:1055472.
36.Achilles SL, Austin MN, Meyn LA, Mhlanga F, Chirenje ZM, Hillier SL. Impact of contraceptive initiation on vaginal microbiota. American journal of obstetrics and gynecology. 2018;218(6):622. e1-. e10.
37.Carter KA, Balkus JE, Anzala O, Kimani J, Hoffman NG, Fiedler TL, et al. Associations between vaginal bacteria and bacterial vaginosis signs and symptoms: a comparative study of Kenyan and American women. Frontiers in Cellular and Infection Microbiology. 2022;12:801770.
38.France MT, Mendes-Soares H, Forney LJ. Genomic comparisons of Lactobacillus crispatus and Lactobacillus iners reveal potential ecological drivers of community composition in the vagina. Applied and environmental microbiology. 2016;82(24):7063-73.
39.Chen X, Lu Y, Chen T, Li R. The female vaginal microbiome in health and bacterial vaginosis. Frontiers in cellular and infection microbiology. 2021;11:631972.
40.Castro J, Machado D, Cerca N. Unveiling the role of Gardnerella vaginalis in polymicrobial bacterial vaginosis biofilms: the impact of other vaginal pathogens living as neighbors. The ISME journal. 2019;13(5):1306-17.
41.McMillan A, Rulisa S, Sumarah M, Macklaim JM, Renaud J, Bisanz J, et al. A multi-platform metabolomics approach identifies novel biomarkers associated with bacterial diversity in the human vagina. arXiv preprint arXiv:150402816. 2015.
42.Ponciano JM, Gómez JP, Ravel J, Forney LJ. Inferring stability and persistence in the vaginal microbiome: A stochastic model of ecological dynamics. bioRxiv. 2024.
43.Ma B, France MT, Crabtree J, Holm JB, Humphrys MS, Brotman RM, et al. A comprehensive non-redundant gene catalog reveals extensive within-community intraspecies diversity in the human vagina. Nature communications. 2020;11(1):940.
44.France MT, Chaudry I, Rutt L, Quain M, Shirtliff B, McComb E, et al. VIRGO2: an enhanced gene catalog of the vaginal microbiome provides insights into its functional and ecology complexity. Nature Communications. 2025.
45.Shah N, Tang H, Doak TG, Ye Y. Comparing bacterial communities inferred from 16S rRNA gene sequencing and shotgun metagenomics.  Biocomputing 2011: World Scientific; 2011. p. 165-76.
46.Ong SH, Kukkillaya VU, Wilm A, Lay C, Ho EXP, Low L, et al. Species identification and profiling of complex microbial communities using shotgun Illumina sequencing of 16S rRNA amplicon sequences. PloS one. 2013;8(4):e60811.
47.    Macklaim JM, Fernandes AD, Di Bella JM, Hammond J-A, Reid G, Gloor GB. Comparative meta-RNA-seq of the vaginal microbiota and differential expression by Lactobacillus iners in health and dysbiosis. Microbiome. 2013;1(1):12.
48.France MT, Fu L, Rutt L, Yang H, Humphrys MS, Narina S, et al. Insight into the ecology of vaginal bacteria through integrative analyses of metagenomic and metatranscriptomic data. Genome biology. 2022;23(1):66.
49.Dos Santos SJ, Copeland C, Macklaim JM, Reid G, Gloor GB. Vaginal metatranscriptome meta-analysis reveals functional BV subgroups and novel colonisation strategies. Microbiome. 2024;12(1):271.
50.Watson E, Reid G. Metabolomics as a clinical testing method for the diagnosis of vaginal dysbiosis. American journal of reproductive immunology. 2018;80(2):e12979.
51.McMillan A, Rulisa S, Sumarah M, Macklaim JM, Renaud J, Bisanz JE, et al. A multi-platform metabolomics approach identifies highly specific biomarkers of bacterial diversity in the vagina of pregnant and non-pregnant women. Scientific reports. 2015;5(1):14174.
52.Afiuni-Zadeh S, Boylan KL, Jagtap PD, Griffin TJ, Rudney JD, Peterson ML, et al. Evaluating the potential of residual Pap test fluid as a resource for the metaproteomic analysis of the cervical-vaginal microbiome. Scientific reports. 2018;8(1):10868.
53.Aldunate M, Srbinovski D, Hearps AC, Latham CF, Ramsland PA, Gugasyan R, et al. Antimicrobial and immune modulatory effects of lactic acid and short chain fatty acids produced by vaginal microbiota associated with eubiosis and bacterial vaginosis. Frontiers in physiology. 2015;6:164.
54.Delgado-Diaz DJ, Tyssen D, Hayward JA, Gugasyan R, Hearps AC, Tachedjian G. Distinct immune responses elicited from cervicovaginal epithelial cells by lactic acid and short chain fatty acids associated with optimal and non-optimal vaginal microbiota. Frontiers in cellular and infection microbiology. 2020;9:446.
55.Delgado-Diaz DJ, Jesaveluk B, Hayward JA, Tyssen D, Alisoltani A, Potgieter M, et al. Lactic acid from vaginal microbiota enhances cervicovaginal epithelial barrier integrity by promoting tight junction protein expression. Microbiome. 2022;10(1):141.
56.Chen L, Li J, Xiao B. The role of sialidases in the pathogenesis of bacterial vaginosis and their use as a promising pharmacological target in bacterial vaginosis. Frontiers in cellular and infection microbiology. 2024;14:1367233.
57.    Schwecht I, Nazli A, Gill B, Kaushic C. Lactic acid enhances vaginal epithelial barrier integrity and ameliorates inflammatory effects of dysbiotic short chain fatty acids and HIV-1. Scientific reports. 2023;13(1):20065.
58.    Muzny CA, Łaniewski P, Schwebke JR, Herbst-Kralovetz MM. Host–vaginal microbiota interactions in the pathogenesis of bacterial vaginosis. Current opinion in infectious diseases. 2020;33(1):59-65.
59.Muzny CA, Sobel JD. The role of antimicrobial resistance in refractory and recurrent bacterial vaginosis and current recommendations for treatment. Antibiotics. 2022;11(4):500.
60.Shvartsman E, Hill JE, Sandstrom P, MacDonald KS. Gardnerella revisited: species heterogeneity, virulence factors, mucosal immune responses, and contributions to bacterial vaginosis. Infection and immunity. 2023;91(5):e00390-22.
61.Liang Y, Zhao C, Wen Y, Sheng D, Wei T, Hu T, et al. Modulation of local immunity by the vaginal microbiome is associated with triggering spontaneous preterm birth. Frontiers in Immunology. 2024;15:1481611.
62.Van Oostrum N, De Sutter P, Meys J, Verstraelen H. Risks associated with bacterial vaginosis in infertility patients: a systematic review and meta-analysis. Human reproduction. 2013;28(7):1809-15.
63.Lokken EM, Manhart LE, Kinuthia J, Hughes JP, Jisuvei C, Mwinyikai K, et al. Association between bacterial vaginosis and fecundability in Kenyan women planning pregnancies: a prospective preconception cohort study. Human Reproduction. 2021;36(5):1279-87.
64.Haahr T, Jensen J, Thomsen L, Duus L, Rygaard K, Humaidan P. Abnormal vaginal microbiota may be associated with poor reproductive outcomes: a prospective study in IVF patients. Human reproduction. 2016;31(4):795-803.
65.Singer M, Borg M, Ouburg S, Morré SA. The relation of the vaginal microbiota to early pregnancy development during in vitro fertilization treatment—A meta-analysis. Journal of gynecology obstetrics and human reproduction. 2019;48(4):223-9.
66.Skafte-Holm A, Humaidan P, Bernabeu A, Lledo B, Jensen JS, Haahr T. The association between vaginal dysbiosis and reproductive outcomes in sub-fertile women undergoing IVF-treatment: a systematic PRISMA review and meta-analysis. Pathogens. 2021;10(3):295.
67.Bernabeu A, Lledo B, Díaz MC, Lozano FM, Ruiz V, Fuentes A, et al. Effect of the vaginal microbiome on the pregnancy rate in women receiving assisted reproductive treatment. Journal of assisted reproduction and genetics. 2019;36(10):2111-9.
68.Franasiak JM, Werner M, Juneau C, Tao X, Landis J, Zhan Y, et al. Endometrial microbiome at the time of embryo transfer: next-generation sequencing of the 16S ribosomal subunit. Journal of assisted reproduction and genetics. 2016;33(1):129-36.
69.Moreno I, Simon C. Deciphering the effect of reproductive tract microbiota on human reproduction. Reproductive medicine and biology. 2019;18(1):40-50.
70.Vitale SG, Ferrari F, Ciebiera M, Zgliczyńska M, Rapisarda AMC, Vecchio GM, et al. The role of genital tract microbiome in fertility: a systematic review. International journal of molecular sciences. 2021;23(1):180.
71.Punzón-Jiménez P, Labarta E. The impact of the female genital tract microbiome in women health and reproduction: a review. Journal of assisted reproduction and genetics. 2021;38(10):2519-41.
72.Samama M, Ueno J, Carvalho de Arruda Veiga E, Piscopo RC, Ikeda F, Pires de Lemos N, et al. Vaginal microbiome and its relationship with assisted reproduction: a systematic review and meta-analysis. Life. 2025;15(9):1382.
73.Kindinger LM, Bennett PR, Lee YS, Marchesi JR, Smith A, Cacciatore S, et al. The interaction between vaginal microbiota, cervical length, and vaginal progesterone treatment for preterm birth risk. Microbiome. 2017;5(1):6.
74.Bayar E, Bennett PR, Chan D, Sykes L, MacIntyre DA, editors. The pregnancy microbiome and preterm birth. Seminars in immunopathology; 2020: Springer.
75.Gerede A, Nikolettos K, Vavoulidis E, Margioula-Siarkou C, Petousis S, Giourga M, et al. Vaginal microbiome and pregnancy complications: a review. Journal of Clinical Medicine. 2024;13(13):3875.
76.    Cobo T, Vergara A, Collado MC, Casals-Pascual C, Herreros E, Bosch J, et al. Characterization of vaginal microbiota in women with preterm labor with intra-amniotic inflammation. Scientific Reports. 2019;9(1):18963.
77.Sun Z, Ge X, Qiu B, Xiang Z, Jiang C, Wu J, et al. Vulvovaginal candidiasis and vaginal microflora interaction: Microflora changes and probiotic therapy. Frontiers in cellular and infection microbiology. 2023;13:1123026.
78.cdc.gov. Vulvovaginal Candidiasis (VVC) 2021 [Available from: https://www.cdc.gov/std/treatment-guidelines/candidiasis.
79.    Sharma H, Tal R, Clark NA, Segars JH, editors. Microbiota and pelvic inflammatory disease. Seminars in reproductive medicine; 2014: Thieme Medical Publishers.
80.CDC.gov. Pelvic Inflammatory Disease (PID) 2022 [Available from: https://www.cdc.gov/std/treatment-guidelines/pid.
81.Norenhag J, Du J, Olovsson M, Verstraelen H, Engstrand L, Brusselaers N. The vaginal microbiota, human papillomavirus and cervical dysplasia: a systematic review and network meta‐analysis. BJOG: An International Journal of Obstetrics & Gynaecology. 2020;127(2):171-80.
82.Mortaki D, Gkegkes ID, Psomiadou V, Blontzos N, Prodromidou A, Lefkopoulos F, et al. Vaginal microbiota and human papillomavirus: a systematic review. Journal of the Turkish German Gynecological Association. 2020;21(3):193.
83.Mancilla V, Jimenez NR, Bishop NS, Flores M, Herbst-Kralovetz MM. The vaginal microbiota, human papillomavirus infection, and cervical carcinogenesis: a systematic review in the Latina population. Journal of Epidemiology and Global Health. 2024;14(2):480-97.
84.Qing X, Xie M, Liu P, Feng O, Leng H, Guo H, et al. Correlation between dysbiosis of vaginal microecology and endometriosis: A systematic review and meta-analysis. PLoS One. 2024;19(7):e0306780.
85.Gu Y, Zhou G, Zhou F, Li Y, Wu Q, He H, et al. Gut and vaginal microbiomes in PCOS: implications for women’s health. Frontiers in Endocrinology. 2022;13:808508.
86.Chieng WK, Abdul Jalal MI, Bedi JS, Zainuddin AA, Mokhtar MH, Abu MA, et al. Probiotics, a promising therapy to reduce the recurrence of bacterial vaginosis in women? a systematic review and meta-analysis of randomized controlled trials. Frontiers in Nutrition. 2022;9:938838.
87.Abbe C, Mitchell CM. Bacterial vaginosis: a review of approaches to treatment and prevention. Frontiers in reproductive health. 2023;5:1100029.
88.Beck D, Foster JA. Machine learning techniques accurately classify microbial communities by bacterial vaginosis characteristics. PloS one. 2014;9(2):e87830.
89.Park S, Moon J, Kang N, Kim Y-H, You Y-A, Kwon E, et al. Predicting preterm birth through vaginal microbiota, cervical length, and WBC using a machine learning model. Frontiers in Microbiology. 2022;13:912853.
90.Golob JL, Oskotsky TT, Tang AS, Roldan A, Chung V, Ha CW, et al. Microbiome preterm birth DREAM challenge: Crowdsourcing machine learning approaches to advance preterm birth research. Cell Reports Medicine. 2024;5(1).
91.Chakoory O, Barra V, Rochette E, Blanchon L, Sapin V, Merlin E, et al. DeepMPTB: a vaginal microbiome-based deep neural network as artificial intelligence strategy for efficient preterm birth prediction. Biomarker research. 2024;12(1):25.
92.Bar O, Vagios S, Barkai O, Elshirbini J, Souter I, Xu J, et al. Harnessing vaginal inflammation and microbiome: a machine learning model for predicting IVF success. npj Biofilms and Microbiomes. 2025;11(1):95.
93.Mirzayi C, Renson A, Consortium GS, Analysis M, 84 QCSFCSS-A, Zohra F, et al. Reporting guidelines for human microbiome research: the STORMS checklist. Nature medicine. 2021;27(11):1885-92.
94.    O’Callaghan JL, Turner R, Dekker Nitert M, Barrett HL, Clifton V, Pelzer ES. Re‐assessing microbiomes in the low‐biomass reproductive niche. BJOG: An International Journal of Obstetrics & Gynaecology. 2020;127(2):147-58.
95.Kennedy KM, De Goffau MC, Perez-Muñoz ME, Arrieta M-C, Bäckhed F, Bork P, et al. Questioning the fetal microbiome illustrates pitfalls of low-biomass microbial studies. Nature. 2023;613(7945):639-49.
96.Papoutsoglou G, Tarazona S, Lopes MB, Klammsteiner T, Ibrahimi E, Eckenberger J, et al. Machine learning approaches in microbiome research: challenges and best practices. Frontiers in Microbiology. 2023;14:1261889.
97.Ling W, Lu J, Zhao N, Lulla A, Plantinga AM, Fu W, et al. Batch effects removal for microbiome data via conditional quantile regression. Nature communications. 2022;13(1):5418.
98.Snell KI, Archer L, Ensor J, Bonnett LJ, Debray TP, Phillips B, et al. External validation of clinical prediction models: simulation-based sample size calculations were more reliable than rules-of-thumb. Journal of clinical epidemiology. 2021;135:79-89.
99.McGuire AL, Achenbaum LS, Whitney SN, Slashinski MJ, Versalovic J, Keitel WA, et al. Perspectives on human microbiome research ethics. Journal of Empirical Research on Human Research Ethics. 2012;7(3):1-14.
100.Ma Y, Chen H, Lan C, Ren J. Help, hope and hype: ethical considerations of human microbiome research and applications. Protein & cell. 2018;9(5):404-15.
101.Chuong KH, Hwang DM, Tullis DE, Waters VJ, Yau YC, Guttman DS, et al. Navigating social and ethical challenges of biobanking for human microbiome research. BMC medical ethics. 2017;18(1):1.
102.Da Silva AS, Anwar S, Park S, Park S, Goodfellow L, Sergaki C. The untapped potential of vaginal microbiome diagnostics for improving women’s health. Frontiers in cellular and infection microbiology. 2025;15:1595182.